eIF3X Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87345
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human eIF3X. Peptide sequence: SVFTDGDLGDSGKRKKGLEMDPIDCTPPEYILPGSRERPLCPLQPQNRDW The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for eIF3X Antibody
Western Blot: eIF3X Antibody [NBP2-87345]
Western Blot: eIF3X Antibody [NBP2-87345] - Host: Rabbit. Target: CLUH. Positive control (+): HeLa Cell Lysate (HL). Negative control (-): Human Liver Tumor (T-LI). Antibody concentration: 3ug/mlWestern Blot: eIF3X Antibody [NBP2-87345]
Western Blot: eIF3X Antibody [NBP2-87345] - Host: Rabbit. Target Name: CLUH. Sample Tissue: Human Fetal Liver. Antibody Dilution: 1.0ug/mlWestern Blot: eIF3X Antibody [NBP2-87345]
Western Blot: eIF3X Antibody [NBP2-87345] - Host: Rabbit. Target Name: KIAA0664. Sample Tissue: Human A549 Whole Cell. Antibody Dilution: 1ug/mlApplications for eIF3X Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: eIF3X
Alternate Names
CLU1, DKFZp686L05242, DKFZp686M09233, FLJ23672, hypothetical protein LOC23277, KIAA0664
Gene Symbol
CLUH
Additional eIF3X Products
Product Specific Notices for eIF3X Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...